[{"Assets_0_Q1_USD":372238000.0,"CommonStockSharesOutstanding_0_Q1_shares":330578168.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-38089000.0,"NetIncomeLoss_1_Q1_USD":-24431000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":328712000.0,"StockholdersEquity_0_Q1_USD":140871000.0,"EarningsPerShareBasic_1_Q1_USD":-0.07,"Ticker":"AMRN","CIK":"897448","name":"AMARIN CORP PLCUK","OfficialName":"Amarin Corporation plc","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265593617.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190501"}]